Annemijn Algra (@annemijn_algra) 's Twitter Profile
Annemijn Algra

@annemijn_algra

Stroke Neurologist (almost finished 😎) from 🇳🇱, with a special interest in SAH/ICH, research communication, innovation | Chair of ESOC2024 PR Committee 🧠

ID: 975459717442129920

linkhttps://akademienl.social/@annemijn_algra calendar_today18-03-2018 19:51:34

551 Tweet

615 Takipçi

1,1K Takip Edilen

European Stroke Org (@esostroke) 's Twitter Profile Photo

Taking sustainability to heart! 🌍 CPG Chair, Robin Lemmens, chose the eco-friendly route by boarding a train in Leuven. We're awaiting his arrival in Basel&can't wait for #ESOC2024 to kick off this Wednesday. Join us: eso-stroke.org/esoc2024/regis… #stroketwitter #voiceofstroke #stroke

Taking sustainability to heart! 🌍 CPG Chair, Robin Lemmens, chose the eco-friendly route by boarding a train in Leuven. We're awaiting his arrival in Basel&can't wait for #ESOC2024 to kick off this Wednesday. Join us: eso-stroke.org/esoc2024/regis…
#stroketwitter #voiceofstroke #stroke
European Stroke Org (@esostroke) 's Twitter Profile Photo

#ESOC2024 large #RCT session kick-off with the #PROMOTE #trial 👇👏 The #trial reveals potential of a #polypill (consisting of antihypertensives & a statin) intervention in #stroke & cognitive impairment #prevention. #voiceofstroke @ESOStroke

#ESOC2024 large #RCT session kick-off with the #PROMOTE #trial 👇👏

The #trial reveals potential of a #polypill (consisting of antihypertensives & a statin) intervention in #stroke & cognitive impairment #prevention.

#voiceofstroke @ESOStroke
European Stroke Org (@esostroke) 's Twitter Profile Photo

The #TASTE #trial supports the use of #Tenecteplase for acute ischemic #stroke <4.5h Though neutral in the intention-to-treat analysis, non-inferiority demonstrated in the per-protocol analysis. Now @ #ESOC2024 👇 European Stroke Org #voiceofstroke

The #TASTE #trial supports the use of #Tenecteplase for acute ischemic #stroke &lt;4.5h

Though neutral in the intention-to-treat analysis, non-inferiority demonstrated in the per-protocol analysis. Now @ #ESOC2024 👇

<a href="/ESOstroke/">European Stroke Org</a> #voiceofstroke
European Stroke Org (@esostroke) 's Twitter Profile Photo

The #CHARM #trial - now at #ESOC2024 - shows 📢: IV #glibenclamide, a drug reducing cerebral edema, did not improve mRS at 3M in patients with large hemispheric #stroke However, the drug seems safe & may be promising for medium-large strokes 👇🧠 #voiceofstroke @ESOStroke

The #CHARM #trial - now at #ESOC2024 - shows 📢:

IV #glibenclamide, a drug reducing cerebral edema, did not improve mRS at 3M in patients with large hemispheric #stroke 

However, the drug seems safe &amp; may be promising for medium-large strokes 👇🧠

#voiceofstroke @ESOStroke
European Stroke Org (@esostroke) 's Twitter Profile Photo

New #ANNEXA-I secondary analysis demonstrates the importance of limiting hematoma growth to improve mortality and functional outcomes in anticoagulant-related #ICH 🩸🧠 Results now @ #ESOC2024 👇 #voiceofstroke @ESOStroke

New #ANNEXA-I secondary analysis demonstrates the importance of limiting hematoma growth to improve mortality and functional outcomes in anticoagulant-related #ICH 🩸🧠

Results now @ #ESOC2024 👇 #voiceofstroke @ESOStroke
European Stroke Org (@esostroke) 's Twitter Profile Photo

Despite severe disability associated with survival, #SWITCH provides weak evidence for decompressive #craniectomy for severe deep #ICH 🩸🧠 Now at #ESOC2024 & simultaneously in the The Lancet Neurology 👇👏 #ESOC2024 #voiceofstroke @ESOStroke Urs Martin Fischer

Despite severe disability associated with survival, #SWITCH provides weak evidence for decompressive #craniectomy for severe deep #ICH 🩸🧠

Now at #ESOC2024 &amp; simultaneously in the <a href="/TheLancetNeuro/">The Lancet Neurology</a> 👇👏

#ESOC2024 #voiceofstroke @ESOStroke <a href="/FishingNeurons/">Urs Martin Fischer</a>
European Stroke Org (@esostroke) 's Twitter Profile Photo

The #CONVINCE #trial – now @ #ESOC2024 shows new evidence for #Colchicine in the #prevention of recur. CV events in #stroke. - Prim. analysis: no reduction of recur stroke & CV events - Sec. analyses: reduced events, also in cor. artery subgroup 👇 European Stroke Org #voiceofstroke

The #CONVINCE #trial – now @ #ESOC2024 shows new evidence for #Colchicine in the #prevention of recur. CV events in #stroke. 

- Prim. analysis: no reduction of recur stroke &amp; CV events
- Sec. analyses: reduced events, also in cor. artery subgroup 👇

<a href="/ESOstroke/">European Stroke Org</a> #voiceofstroke
European Stroke Org (@esostroke) 's Twitter Profile Photo

The #PESTO #trial found no evidence to support use of arthritis medication #etanercept, sometimes prescribed ‘off-label’ to chronic #stroke patients. An important scientific answer to a question raised by the Stroke Survivors Foundation community Now @ #ESOC2024 👇@ESOStroke #voiceofstroke

The #PESTO #trial found no evidence to support use of arthritis medication #etanercept, sometimes prescribed ‘off-label’ to chronic #stroke patients. An important scientific answer to a question raised by the <a href="/strokesurvivors/">Stroke Survivors Foundation</a> community
Now @ #ESOC2024 👇@ESOStroke #voiceofstroke
Annemijn Algra (@annemijn_algra) 's Twitter Profile Photo

Highlighted in the European Stroke Org press portal today — an important study illustrating shocking disparities in #stroke #mortality according to level of #income & #education 👇🏻 eso-stroke.org/wp-content/upl…

European Stroke Org (@esostroke) 's Twitter Profile Photo

🏃 Over 160 delegates at #ESOC2024 laced up their running shoes bright and early at 7:00 CEST for the Stroke Run! What a fantastic start to the day, promoting health and #stroke awareness among our community and beyond. #StrokeAwareness #StrokeResearch #StrokeScience

Thomas Meinel (@totomynell) 's Twitter Profile Photo

Inspiring ! What a determination and reminder to take the patient perspective. #stroke affects 1 in 4 and equally us stroke physicians

European Stroke Org (@esostroke) 's Twitter Profile Photo

#TRACE3 RCT: TNK (0.25mg/kg) vs BMT for stroke patients between 4.5 - 24h without access to EVT. TNK improved excellent outcome at 90d (RR 1.4 🙌) with no signif. increase in sICH rates ❌️ TNK seemed beneficial across all subgroups #VoiceOfStroke Stroke Trials Stroke: Vascular and Interventional Neurology

#TRACE3 RCT: TNK (0.25mg/kg) vs BMT for stroke patients between 4.5 - 24h without access to EVT. TNK improved excellent outcome at 90d (RR 1.4 🙌) with no signif. increase in sICH rates ❌️ TNK seemed beneficial across all subgroups #VoiceOfStroke <a href="/StrokeCliTrials/">Stroke Trials</a> <a href="/SVINJournal/">Stroke: Vascular and Interventional Neurology</a>
Adnan Mujanović (@adnan_mujanovic) 's Twitter Profile Photo

The ELAN Trial RCT subanalysis ⏰️ Early vs late start of anticoagulations does not seem to have treatment effect heterogeneity on safety outcomes (sICH, recurrent stroke, mRS>3) ✅️ However, 25%⬆️ risk for mRS>3 in people with PH! Roman Rohner #ESOC2024 #VoiceOfStroke

<a href="/ELAN_Trial/">The ELAN Trial</a> RCT subanalysis ⏰️ Early vs late start of anticoagulations does not seem to have treatment effect heterogeneity on safety outcomes (sICH, recurrent stroke, mRS&gt;3) ✅️ However, 25%⬆️ risk for mRS&gt;3 in people with PH!  <a href="/rorohner/">Roman Rohner</a>
#ESOC2024 #VoiceOfStroke
European Stroke Org (@esostroke) 's Twitter Profile Photo

#REMOTECAT 🐱 remote ischemic conditioning (RIC) for stroke patients showed numerically higher rates of mRS 0-2 at 90D but no significant differences 🚫 Pts with low NIHSS and no LVO might have benefit of RIC ✅️ #ESOC2024 #VoiceOfStroke

#REMOTECAT 🐱 remote ischemic conditioning (RIC) for stroke patients showed numerically higher rates of mRS 0-2 at 90D but no significant differences 🚫 Pts with low NIHSS and no LVO might have benefit of RIC ✅️ #ESOC2024 #VoiceOfStroke
European Stroke Org (@esostroke) 's Twitter Profile Photo

#RICH2 RCT: Remote ischemic conditioning (RIC) for spontaneous ICH did not show a difference for mRS 0-2 at 90D with comparable safety outcomes (except ⬆️ pain in the ICH group) TREND-IVT study 🇨🇳 #ESOC2024 #VoiceOfStroke

#RICH2 RCT: Remote ischemic conditioning (RIC) for spontaneous ICH did not show a difference for mRS 0-2 at 90D with comparable safety outcomes (except ⬆️ pain in the ICH group) <a href="/WenboZhaoXWH/">TREND-IVT study 🇨🇳</a>
 
#ESOC2024 #VoiceOfStroke
European Stroke Org (@esostroke) 's Twitter Profile Photo

In a cluster-randomized #trial, a Dutch team showed that screening for emotional & cogn. problems in #stroke patients going home may: - ⬆️Improve QoL @ 3 & 12M - ⬇️Reduce fear @ 3M A simple intervention may improve important QoL outcomes! 👏 #ESOC2024 #voiceofstroke

Annemijn Algra (@annemijn_algra) 's Twitter Profile Photo

In the train back from Basel 🇨🇭 🚆 👋 Reflecting on all the great #stroke science from #ESOC2024 & enjoying reading the session reports (👉🏻 eso-stroke.org/tag/esoc-2024/). What are you taking back to the clinic? #esoctaketotheclinic 🚑 🧪 💊 🧠 💡👇🏻